Interocular retinal asymmetry and cognitive frailty: A prospective cohort study
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.14437 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Yung-Sung Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Retina, Frailty. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council of Taiwan, Sequencing and Biochemistry core, Department of Medical Research, National Taiwan University Hospital.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
INTRODUCTION The retinal nerve fiber layer (RNFL) or ganglion cell–inner plexiform layer (GC‐IPL) is associated with cognitive impairment. However, the relationship between retinal asymmetry and cognitive frailty (CF) remains unknown. METHODS Two hundred twenty‐two community‐dwelling older adults were assessed starting in 2015 and underwent biennial cognitive and frailty evaluations until 2022. Retinal asymmetry was defined as the absolute interocular retinal difference. Generalized linear mixed models estimated the risk of CF over time. RESULTS Among the participants, 158 completed the 4‐year follow‐up. Greater baseline GC‐IPL asymmetry was associated with worsening CF over time (adjusted odds ratio = 1.06; 95% confidence interval [CI] = 1.03, 1.10), with handgrip strength asymmetry significantly modifying this association ( p interaction = 0.02). GC‐IPL asymmetry was associated with cognitive impairment ( = −1.69 × 10 −2 ; 95% CI = −3.13 × 10 −2 , −0.25 × 10 −2 ) but not with physical frailty. RNFL showed no significant association with CF. DISCUSSION Interocular GC‐IPL asymmetry might be a new biomarker for CF in older adults. Highlights Interocular ganglion cell–inner plexiform layer (GC‐IPL) asymmetry was associated with impaired memory–frailty, with handgrip strength asymmetry significantly modifying this association. Interocular GC‐IPL asymmetry was associated with cognitive impairment. Interocular retinal asymmetry might be a structural biomarker of cognitive frailty.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
- Department of Ophthalmology, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan.
- Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
- Department of Ophthalmology, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, United States.
ORCID-Profile: Yung-Sung Lee, Yi-Ting Hsieh, Te-Hsuan Huang, Jeng-Min Chiou, Tao-Chun Peng, Yao-Lin Liu, Jen-Hau Chen, Yen-Ching Chen
Förderung
- National Science and Technology Council of Taiwan
- Sequencing and Biochemistry core, Department of Medical Research, National Taiwan University Hospital
Zitieren
APA
Lee, Y. S., Hsieh, Y. T., Huang, T. H., Chiou, J. M., Peng, T. C., Liu, Y. L., Chen, J. H., & Chen, Y. C. (2025). Interocular retinal asymmetry and cognitive frailty: A prospective cohort study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14437
Vancouver
Lee YS, Hsieh YT, Huang TH, Chiou JM, Peng TC, Liu YL, et al. Interocular retinal asymmetry and cognitive frailty: A prospective cohort study. Alzheimer's & Dementia. 2025. doi:10.1002/alz.14437
BibTeX
@article{Lee2025,
author = {Lee, Yung-Sung and Hsieh, Yi-Ting and Huang, Te-Hsuan and Chiou, Jeng-Min and Peng, Tao-Chun and Liu, Yao-Lin and Chen, Jen-Hau and Chen, Yen-Ching},
title = {Interocular retinal asymmetry and cognitive frailty: A prospective cohort study},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.14437}
}
EUVIMED